Context Therapeutics Inc. (CNTX)
$0.28-6.67%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $26M
- Beta
- 1.72
- P/E (TTM)
- -0.57
- Short % float
- 7.28%
- Days to cover
- 4.0
- SI change
- -31.8%
- 1W
- -12.50%
- 1M
- -20.00%
- vs SPY 1W
- -12.36%
- vs SPY 1M
- -22.51%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CNTX?
- LOPJLB’s latest quantitative signal on Context Therapeutics Inc. (CNTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CNTX in?
- Context Therapeutics Inc. (CNTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Context Therapeutics Inc. (CNTX) do?
- Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the develo…